CHRISTIAN KENDRICK: Open Payments
NPI 1205296407 · ROCKLEDGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,421 in 87 payments from 14 companies in 2025. Trend: 2023 $1,660 · 2024 $1,823 · 2025 $2,421
Food & beverage: $2,322Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $702 |
| Regeneron Healthcare Solutions, Inc. | 9 | $448 |
| GENZYME CORPORATION | 5 | $298 |
| Novartis Pharmaceuticals Corporation | 13 | $197 |
| Incyte Corporation | 3 | $140 |
| Arcutis Biotherapeutics, Inc. | 2 | $137 |
| Organon LLC | 3 | $121 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $118 |
| PFIZER INC. | 1 | $106 |
| Amgen Inc. | 2 | $38 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, Opzelura, Zoryve, LITFULO, COSENTYX, VTAMA.
Industry payments across FL — which companies pay providers there.
